🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MetLife, Inc. (MET)
NYSE: MET · Real-Time Price · USD
98.29
+0.69 (0.71%)
Nov 20, 2026, 11:00 AM EST - Market open
← View all transcripts

J.P. Morgan European Financials Conference

Nov 19, 2026

Summary

New Frontier is ahead of schedule, with 22% EPS growth so far this year and adjusted ROE above 17%. Growth plans span Group Benefits, retirement, asset management and international markets, supported by operating leverage and disciplined capital returns.

Pablo Singzon
Analyst, JPMorgan

Okay. We're going to get started with our next session. I'm Pablo Singzon from the U.S. Insurance team, and I'm extremely pleased to host MetLife at our financials conference this year. So up on stage with me is Michel Khalaf, President and CEO, John McCallion, CFO and Head of MetLife Investment Management. I also want to recognize John Hall from the IR team. Welcome to all, welcome to the audience. To start off with Michel, this is MetLife's first time at the JP Morgan Global Financials Conference. What do you want investors who don't follow MetLife closely to take away from the next 40 minutes?

Michel Khalaf
President and CEO, MetLife

Sure. Well, great to be here, and thanks for having us, Pablo. I think I'll start with the backdrop, which I believe is highly attractive for the industry. Demographic shifts are fueling demand for retirement and savings products. Higher interest rates are constructive for the life industry as well. We're continuing to see the convergence of insurance and asset management. Technology is also expanding access to financial services, including insurance, in many parts of the world. So that's a little bit the backdrop. When we designed our New Frontier strategy, this was about delivering strong growth, attractive returns, and lower risk. Not one or the other, but all three. We feel that given the backdrop, given the trends that we are seeing, we're extremely well-positioned to do that. We are in a lot of the markets that are seeing those trends develop favorably.

In those markets, we have very strong distribution, product, investment capabilities that is supportive of our growth and trajectory. I think the proof of that is in the results that we are posting. I think two years into our strategy, I would say we're ahead of schedule. So far this year, we're delivering 22% EPS growth and above 17% adjusted ROE. If there's one thing that I would want folks to take away from this session, it would be that our business is well-positioned to deliver strong growth, organic growth, generate significant cash flow, and return capital consistently to shareholders. I think this is what we mean when we say that MetLife is a quality compounder.

Pablo Singzon
Analyst, JPMorgan

Then just to follow up on your comment on the strategy, right? If you had to explain New Frontier in a few sentences to someone new to the stock, what would you say?

Michel Khalaf
President and CEO, MetLife

Yeah. Again, I would say it is about strong growth, attractive returns, and delivering those consistently. At the core, the strategy is about us deploying capital and resources to markets and businesses where we have structural advantages. Think about market leadership, think about distribution capabilities, investment capabilities, origination capabilities, and the like. This is sort of what the strategy is about. As I mentioned earlier, I think two years in, I think the strategy is working as intended. We are seeing really good traction, and we are ahead of schedule in terms of delivering on the commitments that we made. Those commitments were significant. They were a step up compared to our prior strategy, our Next Horizon strategy.

We talked about delivering double-digit EPS growth, about delivering an adjusted return on equity of 15%-17%, $25 billion in free cash flow, and reducing our direct expense ratio by 100 basis points over the five-year period. The strategy has four key components. One is continuing to grow and expand growth in our Group Benefits business, which is our flagship business. Two, it is about capitalizing on our unique retirement platforms in the U.S., U.K., and Japan. Three, it is about accelerating growth in asset management. Last but not least is growing and accelerating our growth in some highly attractive international markets. I would say on all these fronts, we are making really good progress. Ultimately, this is a strategy about delivering growth with strong cash generation and an attractive capital return profile when it comes to investors.

Pablo Singzon
Analyst, JPMorgan

Yep. Thanks for that. I will turn it over to John. Maybe walk us through what drives the EPS growth, and I guess the more interesting question is how much of it is in your control versus the markets?

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah. Thanks, Pablo, and great to be here. Thanks for having us. Look, as Michel said, these were a step up in terms of commitments for us, but we have a lot of confidence in delivering on that double-digit EPS growth. I break it down into three things. Organic growth is one, and we see across the platform very strong opportunities. We have seen it for the first nine months this year. Effectively, every business has shown strong growth across all their channels. Organic growth is one. Second is, we have been building operating leverage for some time, and we are seeing that come through. Michel referenced the expense ratio as one metric for us to point to, which is effectively a way of describing unit costs. We have been seeing more efficiency continue to drive through the businesses, so we have significant operating leverage.

The third one is capital efficiency and capital allocation. We've been showing a track record for some time, our ability to deliver and fund attractive returns and organic growth, our ability to consider inorganic M&A, it has to meet a high hurdle, and ultimately, our ability to return excess capital to shareholders consistently over time, and we've been able to do that. We've been able to do all of those things at the same time. As we think about it, obviously, market performance can be a factor, and people will point to variable investment income, which is one of our assets that we allocate our funds to, which basically are LP investments in private equity. It's about 3%-5% of our portfolio. At the end of the day, we're not dependent upon an extraordinary market performance.

It's really within our control, and as I said, it's really organic growth, driving operating leverage, and then consistent capital allocation.

Pablo Singzon
Analyst, JPMorgan

Great. I guess the flip side of good growth and ROEs are cost of equity, right? I think MetLife has been changing its mix to make its earnings more predictable. How is that translating for shareholders, and sort of give us your thoughts on that initiative?

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah, I think not only are we driving strong EPS growth or earnings growth, we're also driving an improved mix and durability around that growth. We talk about our business with two broad engines. We have our capital-light business, which makes up Group Benefits, LATAM, EMEA, and MetLife Investment Management, where you have higher ROE and lower capital intensity. Then we have what we call our capital-driven businesses, which are more retirement spread-oriented, and think about that being retirement and income solutions in the U.S. and then Japan. Again, there, you see strong attractive returns and strong demographic trends to support that. Overall, they're actually complementary. As you raise assets and originate liabilities in the capital-driven, actually, our MetLife Investment Management platform manages those funds, which ultimately turns into fee revenue for MIM. Again, it almost reinforces the other.

Ultimately, you see over time this shift happening. Before we started the last strategy, which was, call it, eight years ago or seven years ago, we were probably about a 60/40 mix, 60/40 meaning capital-driven to capital-light. Over that time, we've shifted to more 50/50, and what's happened is you've seen our ROE enhancement. At the beginning of the last strategy, our target ROE was 12%-14%. Our target ROE right now is 15%-17%. Part of that is a function of the mix of business that we've been driving over time. Overall, while we have strong growth, we also think the quality and the durability of that growth is improving.

Pablo Singzon
Analyst, JPMorgan

Thanks for that. I guess now we can go into the business. Michel, for you, Group Benefits is a business investors know the best. MetLife's in a leading position there. What makes it hard for others to compete with you, and what makes you confident that the business can keep growing?

Michel Khalaf
President and CEO, MetLife

Yeah, I mean, I've said it before, I believe that Group Benefits is the most attractive segment of U.S. Life. It's a capital-light business with high margins and returns. It's a real differentiator for MetLife. We're the market leader by some distance. We're three times the size of our nearest competitor, and we've been consistently growing above market in that business. We say that scale begets scale in Group Benefits. This is because this business requires significant investment in service and capabilities that help strengthen the relationship with brokers, with employers. This, in turn, turns into more scale, and that's how we're able to continue to grow this business, and as I said, grow above market.

A good example I can give you on this front is in leave and absence, where we saw several years ago a trend where more and more states in the U.S. were introducing paid family leave regulation. By speaking with our customers, we knew that this was going to be a pain point for them in terms of administering this business. So we invested in a capability, My Leave Navigator, which has allowed us to significantly grow this business over time, especially as more states come on board with their new regulations. So, this is an example of how our scale enabled us to make the investment that is now fueling our growth. This is a business that we don't sell it on its own. We sell it with four to five additional coverages. So it's helping us also expand the products that we have with customers.

More broadly, I would say we have this is a GDP plus business. We point to us being able to grow at a 4%-7% clip over time. The reason we feel confident in terms of being able to deliver on that growth is that we have very clear strategies to add employers, especially at the lower end of the market, the under 5,000 market, add more products to existing customers. On average, we have three to four products with them. They offer up to 10, so a lot of space to grow there. Last but not least, increasing the take-up rates on employee-paid or voluntary products. Those are the strategies that are going to enable us to grow. Look, our results, I think, demonstrate that we're making really good progress here.

Our earnings in the third quarter were $523 million, a 14% increase year-on-year. We had 5% PFO growth, excluding participating contracts, and sales grew 12%. All in all, this business is continuing to perform very strongly, and we believe that this performance is sustainable as we move forward here.

Pablo Singzon
Analyst, JPMorgan

Another priority for MetLife is retirement. We're also a leader across several lines of business. What's the opportunity for MetLife to grow more there, and how do you plan to take advantage of it?

Michel Khalaf
President and CEO, MetLife

Yeah, I think the combination of demographic shifts and higher interest rates are supportive of growth in the retirement segment. We have very strong origination capabilities in the U.S., in Japan, and in the U.K., and we're capitalizing on those capabilities. We have the advantage of also having an in-house scaled asset manager with strong origination capabilities. This business, again, performed very strongly in the third quarter, 12% earnings growth, and we point to retained liability balances as a proxy to growth in that business, and those were above the 3%-5% range that we sort of aim for. All in all, I think this business is performing really well. One of the advantages that we have is that we're not beholden to a single line of business when it comes to retirement.

We have a diversified portfolio, so pension risk transfer, structured settlements, stable value, U.K. longevity reinsurance. More recently, we entered the U.K. funded re space, as well as retail reinsurance space in the U.S. What this allows us to do is avoid areas that may, from time to time, become overly competitive and lean into areas where we see attractive returns, and I think that's why you're seeing the growth that we are achieving in this business. Our aim is to grow retirement, say, in the 5% range on average, but then we also use third-party capital, given that we see further growth opportunities. So, beyond what our own balance sheet can absorb, we can also tap into third-party capital to fuel further growth.

Pablo Singzon
Analyst, JPMorgan

Actually, that's a good segue. So maybe I'll ask John to talk about that initiative a bit more, right? So you launch a third-party reinsurance company, sidecar Chariot Re, and it's scaled quite quickly. Can you talk about what you're seeing there, the opportunities, and how do you expect growth to develop in that initiative? Sort of, I guess, married to what you're doing organically on your own balance sheet.

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah, sure. I think just leaning into what Michel said, we would describe this as like a growth multiplier. So we're comfortable with a mid-single-digit growth of our own balance sheet to support these businesses, but we see growth beyond that. So, obviously, we bring to the table things like the ability to underwrite and originate those liabilities using our risk management framework, our ability to service those customers and clients, our ability to originate assets to match those liabilities. But at the same time, we can share in the capital needed to support the growth of this business, and that's where the sidecar and Chariot Re can come in. So it's been launched a little over a year ago. Since that time, we've raised roughly $2 billion of capital that can support up to $20 billion of liabilities.

We have roughly a little $11 billion to $12 billion in the entity right now. We had a close recently in September where we were oversubscribed, $700 million of capital we raised, anchored by Chubb, and then also ourselves and General Atlantic, who's another sponsor partner of ours. So, overall, what that does is while we get to participate in the growth with our own balance sheet, but also with other capital to share in the capital to support the growth, and then those assets are also managed by MetLife Investment Management, which allows fees to be generated to support our capital light business. So overall, this becomes a growth multiplier for us.

Pablo Singzon
Analyst, JPMorgan

Yeah, makes sense. John, you also lead MetLife Investment Management, so quite a unique perspective there. After adding PineBridge last year, how do you expect to grow there, and where will it show up in the numbers or results?

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah, sure. As you heard from Michel earlier, when it comes to the strategy and the four priorities, this is one of them. How do we accelerate the growth in our asset management business? Overall, this fits very nicely into our capital light business, so again, another business that can help enhance, drive ROE, drive strong free cash flow. We recently acquired and closed on PineBridge at the beginning of the year, so we're a little less than a year into the integration. I'd say overall, we're very pleased with the progress that we're making. Year- to- date, earnings are up 19%, and as we said in our outlook call back in February, we expect the near term to be a 15%-20% growth in EBITDA on a go-forward basis.

I think our goal is for this to become a greater proportion of MetLife earnings and contributor, which should enhance ROE and free cash flow. From an integration perspective, first of all, PineBridge is very complementary to what we had. We are already a scaled asset manager, top 25 on using AUM, close to $725 billion of assets under management. We're the number one infrastructure lender in the world. We're the top private placement, private corporate private placement manager of insurance company balance sheets. Again, a leader already, but what PineBridge provided us was it enhanced our capabilities, particularly in the higher yielding space. It brought a very significant leveraged finance platform and CLOs, highly successful private credit platform that we've been able to merge with our own, and then also the geographic breadth that it brings.

It had significant clients outside the U.S., in Asia, including EMEA. Again, that distribution allows us to bring more products to more clients and more successfully have an opportunity to grow collectively together. Overall, very pleased both commercially and operationally about how the integration's been going.

Pablo Singzon
Analyst, JPMorgan

Thanks. Turning back to Michel. Let's speak about the international business, right? Another New Frontier priority, I think, very good and complementary addition to the strong growth you are already showing in the U.S. The first question is, how does Asia fit into the growth story there in international, and how are higher rates shaping customer demands, specifically in Japan and Korea?

Michel Khalaf
President and CEO, MetLife

Sure. Yeah, I would say Asia is very central to our growth story. It is a scaled market with important demographic shifts that are supportive of long-term growth. We have a strong presence in Asia, a combination of mature markets, Japan and Korea namely, and then longer term secular growth markets in India and China. We are seeing very strong growth. I think Asia is setting new records when it comes to sales, strong earnings as well, $550 million in the third quarter. I think that speaks to the traction that we are seeing in Asia overall. Japan is our largest market outside the U.S. In 2019, when we launched our first strategy, we were the sixth-largest player in the market. We are number four now. I think that speaks to the growth that we have been able to generate in Japan.

I think Japan has new energy, I would say.

It is a new dawn in that market. On the one hand, an aging population is creating additional needs when it comes to retirement savings and healthcare. That is also creating a new cohort of customers, younger customers, that did not traditionally start saving early. Now, there is a recognition that that is important. The other, I think, important trend in Japan, which is driven by inflation and higher rates, is that a lot of the savings in Japan, close to 50%, sit in cash and bank deposits. That becomes punitive in an inflationary environment. Those are starting to move also into a market-linked instrument, which benefits the industry overall. MetLife is extremely well-positioned to continue to capture these trends. We have very strong distribution capabilities, very diversified from a distribution standpoint, and we have a track record of product innovation in that market.

With the increase in yen rates, we are seeing a shift. Last year, 70% of our business was in U.S. dollars, 30% in yen. This year, it is 50/ 50 yen and U.S. dollars. We had seen that trend coming, and we had introduced a number of yen-denominated products that are performing very well. We have also taken some of the expertise that we developed in Japan on the product side to Korea, and that is again helping fuel a lot of the growth that we are seeing in that market. All in all, really pleased with how Asia is performing, and as I mentioned, I think some of the trends that we are seeing are sustainable, and we believe that we are going to be well-positioned to continue to capture those.

Pablo Singzon
Analyst, JPMorgan

Okay. Let's turn now to Latin America, right? What's driving that, and how much of that do you think is durable?

Michel Khalaf
President and CEO, MetLife

Yeah, let me start by saying that we're the number one player in Latin America, number one in Mexico, number one in Chile, and we're the fastest-growing insurance company in Brazil. Latin America, I would say, has seen really good momentum, especially post-COVID, both top line and bottom line. I think to give you a sense of that, our earnings in LATAM will have doubled from before COVID, if you think about this year, and we're on track to deliver about $1 billion in earnings from the region. I think our advantages, again, are diversified product and distribution capabilities, but we've also been able to innovate in that market. A few years ago, we saw a trend emerging with a lot of digital native banks that had come in and taken significant share. That's now also extended to some of the e-commerce players and retailers.

We built a capability we call MetLife Xcelerator that allows us to integrate seamlessly into that ecosystem and offer embedded insurance. That's now 20% of our sales in LATAM, so it gives you a sense of the traction that we're seeing there, and that's fueling a lot of our growth. And it's a capability that we're now importing into EMEA, where we see a similar trend developing. All in all, again, strong momentum in LATAM, and we have every reason to believe that it's sustainable.

Pablo Singzon
Analyst, JPMorgan

Thanks. All right. Shifting back to John. Variable investment income was well above expectations this recent quarter, tied to the strength of certain private equity and VC exposure. I guess, how do you think about those exposures specifically and the broader VII portfolio over time?

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah. It was a very strong quarter. I mean, if you step back and think about this asset class and our allocation, I mean, ultimately, this has been a long-term investment philosophy for us. From a liability perspective, you are backing a longer tail of the liabilities. One of the things that I would highlight is we have been a consistent, seasoned investor. We are well-diversified across 700 investments, 200 managers. This was not like a quarterly trade. This is something that we have developed and built an expertise on over time. As a result, we saw some strong returns last quarter. About 25% of our portfolio is in venture capital, so we saw a lot of the benefits that we have seen over the last four or five months from VC-oriented investments come through. That was certainly an enhancement.

But even the rest of the portfolio performed well, too. Overall, it was a very strong quarter. The other thing I would highlight there is that this was not all mark-to-market. We had about $600 million of realizations in the quarter, so that was actually cash coming in from this asset class. Again, that is a function of being a seasoned investor over multiple vintages for quite some time, and it really becoming a core capability of ours. Overall, it is a complementary asset class to our profile. It starts with the liabilities and when it makes sense to have longer duration-oriented assets. Over time, as rates have risen, we have seen probably more distributions than we could do in terms of capital contributions. So there has been a net decline in the assets.

But overall, it is still an attractive asset class and one that we think is attractive over the long term.

Pablo Singzon
Analyst, JPMorgan

Okay. Shifting to another aspect of the investment portfolio. Investors are quite focused these days on credit, commercial real estate, private markets, and interest rates have moved higher. Just your thoughts on the resiliency of the portfolio, and maybe just remind us certain exposures that investors are most concerned about, like AI and such, but—

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Sure

Pablo Singzon
Analyst, JPMorgan

—just high-level comments there would be helpful.

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah. Let me start with, again, it starts with our liabilities, right? We have illiquid funding that allows us to have illiquid assets. I think that's really core and important when you start here, because ALM is a critical component. If you have liquid funding and illiquid assets, those things tend to go against you at times. That's really important to start. I think second thing is that we've been doing this for decades, even you might argue century, right? We're leaning into expertise that we've built over time in private markets and private assets. In the private fixed income area, which would include things like middle market direct lending and other higher-yielding strategies, about 95% of that portfolio is investment grade. That's really probably a theme for all of the private-oriented investments.

We're generally up in quality when it comes to where we invest across the private asset spectrum. Then, on the middle market direct lending, it's a smaller proportion of our allocation. Still important, but less than 1% of our balance sheet, and we don't have any BDCs. Then you look at a place like real estate, another private asset where we have significant expertise that we lean into. Again, we tend to be up in quality when it comes to that. Obviously, we've gone through a more severe cycle of late, which is also important when you think about where you want to invest in the structure from our balance sheet perspective. Despite that has had no impact on any of our capital management activity, and I think that's an important message to take away. Overall, private assets are an important function of how we operate.

Because we have illiquid assets, we can lean into expertise that we built over time. As you turn to higher rates, I mean, in general, higher rates are constructive, as Michel said in the beginning, to the demand for the products that we issue. Over time, higher rates likely improve margins gradually, particularly as you have the roll-off and reinvest occur. That's certainly a positive backdrop as well. I think in this environment, we see things like credits fairly stable still. Our exposure to things like data centers and hyperscalers, fairly modest, each of them being less than 1%, and we disclosed that most recently in our third quarter. We feel very comfortable with the portfolio we built. We've leaned into things like diversification, where maybe others lean into concentration. We tend to use diversification as a risk management tool.

But all in all, we're very comfortable with where we stand.

Pablo Singzon
Analyst, JPMorgan

Thanks. Shifting topics here, so you guys track and disclose the value of new business, right? Which essentially measures the return on capital used to fund new businesses that you write. Less popular in the U.S., right? More followed outside. But I guess the question is, how has it trended for you? What products underlie that new business IRR, and ultimately, how does it show up in the overall ROE over time?

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Yeah. It's been a very important aspect for us, predominantly culturally. I'll just start with some of the metrics. We report every third quarter annually our value of new business for the prior year. We deployed about $3.8 billion of capital and had value of new business of $2.8 billion, an IRR of 19% unlevered, and five-year payback. If you go back a decade when we started this, those IRRs were 12%, it was a 12% IRR, and it was an eight-year payback. So you've seen a significant move in just the value that we've been able to generate for every dollar that we invest. I'd say predominantly a function of us putting these tools in the hands of our leaders. And that's product design, seeing the power of driving unit cost down, other factors as well.

If you think about our ROE and what's happened over time, having a 12%-14% ROE in the beginning of Next Horizon, our last strategy, now having one at 15%-17%, about a 300 basis point move. This has been a significant driver to that, and I think, again, probably most importantly, a cultural driver for us.

Pablo Singzon
Analyst, JPMorgan

Okay. Then, maybe, back to Michel. Let's close with capital management and capital allocation. Can you just remind the audience how you decide between allocating or reinvesting capital in the business, allocating to buybacks, dividends, or M&A?

Michel Khalaf
President and CEO, MetLife

Sure. I would start by saying we've been very consistent in terms of our approach here. Our first order priority is to support organic growth, and to the point that John just made, you can see from our disclosures how attractive the returns and the paybacks are on this growth. So that's always our first order priority. M&A is a strategic capability, but we're very disciplined when it comes to M&A. I would say M&A has a high bar to clear in terms of we compare it to other potential uses of capital. Also, as I mentioned, it's strategic, meaning that we're always going to look for things that fit strategically and culturally. We pointed to areas where we might consider M&A in terms of adding, not transforming, and those are asset management and Group Benefits. Outside of that would be opportunistic.

I would say less likely in Group Benefits, just because I think that we have everything that we need. Having said that, we're always in conversations with customers to see if there's something else that we should consider. Asset management, more likely. We talked about the PineBridge Investments acquisition, so we're now focused on integration, and we're making good progress there. But we think this is a space that's going to continue to consolidate, and I think MetLife would be an attractive consolidator in that space. But again, we'd be looking for an adjacency or a solution, a capability that can help accelerate our growth trajectory. That's the kind of things we would be considering there. Then outside of that, excess capital belongs to shareholders, and we will return it in the form of an attractive dividend yield that grows commensurate with growth in our earnings.

Think 4% or 5% there. Then through buybacks, and again, here we've been very consistent in terms of our buyback activity, and we're on track to deliver what we said from a buyback perspective at the beginning of the year. So that's the philosophy. It's been very consistent, and we are sticking to it as we move forward here.

Pablo Singzon
Analyst, JPMorgan

Great. I think we were able to cover a lot of ground there. So good food for thought. Thank you, Michel , John, the other John, and thank you everyone else. Have a good day.

Michel Khalaf
President and CEO, MetLife

Thank you.

John McCallion
CFO and Head of MetLife Investment Management, MetLife

Thank you.

Michel Khalaf
President and CEO, MetLife

Appreciate it.